Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.
We examined 741 urinary tract isolates of the Morganella-Proteus-Providencia group, including the recently defined species Proteus penneri, for susceptibilities to aminoglycosides, semisynthetic penicillins, and cephalosporins. The data emphasize the importance of identification to the species level on the basis of marked species differences in patterns of susceptibility.
Istituto di Medicina Sperimentale, Facoltà di Medicina e Chirurgia, Università degli Studi G. D'Annunzio, Chieti, Italy.
R
R
Piccolomini
L
L
Cellini
N
N
Allocati
A
A
Di Girolamo
G
G
Ravagnan
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae / Q000187:drug effects*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011511:Proteus / Q000187:drug effects*; D011532:Providencia / Q000187:drug effects; D014552:Urinary Tract Infections / Q000382:microbiology*
D000900:Anti-Bacterial Agents